Skip to product information
1 of 1

Pediatapp Neo (Phenylephrine Hydrochloride + Brompheniramine Maleate)

Pediatapp Neo (Phenylephrine Hydrochloride + Brompheniramine Maleate)

Regular price ₱150.00 PHP
Regular price Sale price ₱150.00 PHP
Sale Sold out
Taxes included.
Form & Size
Quantity
Pediatapp Neo is a trusted pediatric decongestant and antihistamine combination medication designed to provide effective relief from nasal congestion and allergy symptoms in children. This pharmaceutical formulation contains Phenylephrine Hydrochloride, a potent nasal decongestant that works by narrowing blood vessels in the nasal passages to reduce swelling and restore clear breathing, and Brompheniramine Maleate, a first-generation antihistamine that blocks histamine receptors to alleviate allergic reactions, itching, and inflammatory responses.

Ideal for managing seasonal allergies, common cold symptoms, and upper respiratory congestion in pediatric patients, Pediatapp Neo offers rapid symptom relief while maintaining a safety profile appropriate for children's use. The dual-action formula addresses multiple symptoms simultaneously—clearing nasal passages while reducing histamine-mediated discomfort—making it a convenient single-dose solution for parents seeking comprehensive cold and allergy management.

Pediatapp Neo is formulated with pediatric dosing in mind, ensuring appropriate strength and safety for younger patients. This medication is commonly recommended during cold and flu seasons, allergy flare-ups, and periods of environmental irritation when children experience congestion-related discomfort that interferes with sleep, feeding, or daily activities.

Always follow the dosage instructions provided on the package or as directed by a healthcare professional. Store Pediatapp Neo in a cool, dry place away from direct sunlight and keep it out of reach of children. Consult a pediatrician or pharmacist before use if your child has underlying health conditions, is taking other medications, or experiences adverse reactions.
View full details